Improving quality of life after heart valve replacement
Official title: Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
Run by Sheba Medical Center · NCT02023060 · Data updated 2026-11-12
This study looks at how people feel and do after getting a heart valve replacement to see if there are patterns that could help improve future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 110 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sheba Medical Center Government |
| Locations | 5 sites (Jerusalem and 4 other locations) |
| Status | Recruiting |
| Started | November 2013 |
| Main results expected | November 2030 |
| Study ends | November 2030 |
| Registry record updated | November 29, 2023 |
| Trial ID | NCT02023060 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients selected for transcatheter heart valve replacement who can provide informed consent.
✕Probably not a fit
Patients who are unable to provide informed consent or are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to track patient characteristics and outcomes following transcatheter heart valve replacement for aortic or mitral valve conditions. By collecting data over time, the study seeks to identify trends that may inform future treatment approaches. Participants will be those selected for the procedure and who provide informed consent. The study does not involve any specific interventions beyond observation.
Why it matters
Potential benefit: If successful, this study could enhance understanding of patient outcomes and improve quality of life for individuals undergoing heart valve replacement.
How similar studies have gone: Other observational studies have shown success in tracking patient outcomes in similar heart valve replacement procedures, suggesting that this approach is validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subject selected for transcatheter heart valve replacement 2. Signed informed consent to participate in the study Exclusion Criteria: 1. Inability to sign written informed consent. 2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).
Where it's running
-
Hadassah Medical Center
Jerusalem, Israel Recruiting -
Shaarei Zedek amedical Center
Jerusalem, Israel Recruiting -
Rabin Medical Center
Petah Tikva, Israel Recruiting -
Sheba Medical Center
Ramat Gan, Israel Recruiting -
Tel Aviv Medical Center
Tel Aviv, Israel Recruiting
Study contacts
- Study coordinator: Israel Barbash, MD
- Phone: +97235305273
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise and nutrition support before and after TAVI for older adults with aortic stenosis
This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.
-
Association Between Aortic Valve Area Changes and Pulmonary Congestion After TAVI
This study tests whether improvements in aortic valve opening after TAVI relate to reductions in lung congestion measured by ultrasound in adults with severe aortic stenosis.
-
Systematic 14-day ambulatory heart monitoring after TAVI
After TAVI, patients with certain heart conduction abnormalities will try 14 days of wearable ECG monitoring to see if it lowers the chances of sudden death, symptomatic heart rhythm problems, or stroke within a year compared to standard follow-up.
-
Echo-AVCS: Drawing AI-powered clues from heart scans to confirm severe aortic stenosis
This study tests an AI-based echocardiography score to help confirm severe aortic stenosis in adults who are also getting CT calcium scoring.
-
TAVI without on-site heart surgery: can selected centers do it safely?
This trial tests whether transcatheter aortic valve implantation can be done safely in certain hospitals that don’t have on-site cardiac surgery, for patients with severe aortic stenosis who are appropriately selected.
-
Willem AI for early detection of aortic stenosis from a 12‑lead ECG
This project will test whether the Willem AI can detect aortic stenosis from routine 12‑lead ECGs in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.